GNH USA

Europe — EMA

Glucosio Con Sodio Cloruro Iii Monico

Sodium Chloride and Glucose Monohydrate Injection for fluid, electrolyte and carbohydrate replacement in clinical settings.

Sodium Chloride, Glucose Monohydrate

Request sourcing

1
Pack/s

What is Sodium Chloride, Glucose Monohydrate?

Glucosio Con Sodio Cloruro Iii Monico is an injectable solution that contains the active ingredients sodium chloride and glucose monohydrate. It is supplied as a sterile intravenous fluid intended for use in clinical settings to provide electrolyte balance and an energy source. The product is manufactured for the EU market and is available by prescription only.

What is Sodium Chloride, Glucose Monohydrate used for?

Glucosio Con Sodio Cloruro Iii Monico is indicated for several clinical situations where fluid, electrolyte, and carbohydrate support are required. It is commonly employed in hospital and emergency environments.

- Replacement of fluid losses due to dehydration, surgery, or trauma - Correction of electrolyte disturbances, especially sodium and chloride deficits - Treatment of mild to moderate hypoglycemia when oral intake is not feasible - Support of parenteral nutrition regimens as a carbohydrate source - Maintenance of intravascular volume during anesthesia or critical care

What are the side effects of Sodium Chloride, Glucose Monohydrate?

Side effects of sodium chloride and glucose monohydrate injection are generally infrequent but may occur with any intravenous therapy. Monitoring during administration helps identify and manage reactions.

Common: - Mild local irritation or pain at the injection site - Transient increase in blood glucose levels - Slight elevation of serum sodium concentration - Temporary feeling of warmth or flushing

Serious: - Severe hypernatremia leading to neurological symptoms - Significant hyperglycemia requiring medical intervention - Allergic reaction such as urticaria, rash, or anaphylaxis - Fluid overload causing pulmonary edema or heart failure - Electrolyte imbalance with marked shifts in chloride levels

What precautions apply to Sodium Chloride, Glucose Monohydrate?

When using Glucosio Con Sodio Cloruro Iii Monico, clinicians should observe several safety considerations to minimize risk. Proper patient assessment and monitoring are essential.

- Verify patient’s electrolyte status and glucose levels before infusion - Adjust infusion rate in patients with renal or cardiac impairment - Avoid rapid administration to prevent sudden shifts in serum sodium - Use caution in patients with known hypersensitivity to any component - Monitor for signs of fluid overload, especially in the elderly - Ensure compatibility with other intravenous solutions before mixing

What does Sodium Chloride, Glucose Monohydrate interact with?

Glucosio Con Sodio Cloruro Iii Monico may interact with other medications, affecting electrolyte balance or glucose control. Review the patient’s medication list prior to use.

Avoid: - Concurrent high‑dose diuretics that may exacerbate sodium loss - Intravenous hypertonic glucose solutions that could cause severe hyperglycemia - Medications that prolong the QT interval when combined with rapid sodium shifts

Use with caution: - Insulin therapy, as glucose infusion may alter insulin requirements - ACE inhibitors or ARBs, which can affect potassium and sodium homeostasis - Corticosteroids, which may increase sodium retention and fluid volume

Frequently asked questions

What is the primary purpose of a sodium chloride and glucose monohydrate injection?+
The injection provides sodium, chloride, and glucose intravenously to restore fluid balance, correct electrolyte disturbances, and supply an immediate energy source.
In which clinical situations is Glucosio Con Sodio Cloruro Iii Monico typically used?+
It is used for fluid and electrolyte replacement, treatment of hypoglycemia, and as part of parenteral nutrition regimens.
How is the solution administered to patients?+
The product is given as an intravenous infusion, usually through a peripheral or central venous line, under controlled rate.
Can this injection be used in pediatric patients?+
Use in children should be based on a physician’s assessment of dosing requirements and clinical need, following pediatric guidelines.
What monitoring is recommended during infusion?+
Blood glucose, serum sodium, chloride, and overall fluid status should be monitored regularly throughout the infusion.
Are there any contraindications for this intravenous solution?+
Contraindications include known hypersensitivity to the ingredients and conditions where rapid sodium loading could be harmful, such as severe hypernatremia.
What are common side effects that patients might experience?+
Common side effects include mild local irritation, transient increase in blood glucose, and a temporary rise in serum sodium.
What serious adverse reactions require immediate medical attention?+
Serious reactions include severe hypernatremia, significant hyperglycemia, allergic reactions like anaphylaxis, and fluid overload leading to pulmonary edema.
How should the solution be stored before use?+
Store the unopened vials in a controlled environment, protected from light, and at temperatures recommended by the manufacturer, typically between 2 °C and 8 °C.
Can this injection be mixed with other intravenous medications?+
Compatibility should be confirmed before mixing; some drugs may cause precipitation or alter electrolyte balance.
Is special equipment needed to administer the injection safely?+
Standard IV infusion sets with appropriate flow regulators are used; infusion pumps may be employed for precise rate control.
What documentation is required for prescribing this product?+
As a prescription‑only medication, a valid medical order specifying dose, rate, and duration must be recorded in the patient’s chart.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Sodium Chloride, Glucose Monohydrate
Route
Intravenous Use
Manufacturer
Monico S.P.A.
Origin
EU

Related products